Plasma tumor markers such as chromogranin A and neuro‐specific enolase are elevated in some advanced pulmonary NECs, but their role in gastroenteropancreatic NEC and gallbladder NEC is not clear.20 This evidence concerns the gene CHGA and neuroendocrine carcinoma.